Headlines are made regularly for the potential benefits of marijuana for medical use. Proponents say that it gives more assistance with less side effects. The FDA is currently conducting clinical trials in a new product named Medchew, a chewing gum infused with 5 mg, while the Government keeps fighting against making it legal in all states. 5 mg of CBD. THC.
“Weed-infused gum for chronic pain,” according to an article written on Herb.co. “Axim Technology expects its gum and also the European Medicines Agency to pass through the FDA by the end of this year. It is to be marketed as a treatment for MS and other syndromes with problems of spasticity. Although Fibromyalgia is not mentioned specifically, it may also be a viable treatment option for spastic muscles who are disabled.
Chewing would provide even more relief, instead of smoking or eating, with no side effects, according to Professor John Zajicek. The THC and CBD are directly absorbed in the mouth, circumventing the liver. Furthermore, the simple chewing act is thought to be good for the patient. Zajicek claimed that it provides stress relief and helps slow cognitive loss in older people. Thus, without all the negative the patient gets double the positive. Chewing is more acceptable socially than to smoke or take a pill.
Axim Technology has the product patent and a CBD gun laced under the moniker Canchew has already been placed on the market. Medical marijuana, INC has 46% of Axim and plans to release additional products related to the weed in the future.
It can depend very well on competitors to see how this happens. While Axim has gum rights, they are also competing with GW Pharmaceuticals whose Sativex spray is available in 27 countries, not only the United States. A spray called Epidolex was approved by the FDA in the US.
To control the genetics and to provide the most efficient drugs, GW Pharmaceuticals grows its own plants. Axim works with the government of the Netherlands, on the other hand. While Axim benefits from Gw Pharmaceutical evidence of the safety and efficacy of cannabis-laced products, it must also persuade the FDA and DEA.
Axim released Marinol, a gum used to treat Cancer or patients with HIV since this article was published. This is a synthetic THC and patients who use it complain about different side effects that make it virtually impossible to take advantage of. If Medchew conducts current medical trials, synthetic version problems can be resolved.
But does the millions of Fibromyalgia patients receive this promise? It could very well, according to one source. In a Leafly article on “Can cannabis treat fibromyalgia better than prescription medicines? In 2014 a survey of 1300 fibromyalgic sufferers was conducted by the National Pain Association. Cannabis has been tried for pain among these patients, 30% or 390. It was very effective for those who tried it 62 percent. 33% reported some assistance and only 8% stated that they had no aid whatsoever.
The same study asked about approved Lyrica, Savella and Cymbalta medicines from the FDA. Only 8-10% reported that they were very effective, while 60-65% said they didn’t help.
Researchers found in a double-blind study of a synthetic cannabinoid nabilone as an addition to other therapies. However, the expenditure for a large number of patients would make the medicine unattainable at $1,000 for 30 pills and a large majority of respondents preferred a more individually controlled botanical solution.
Cannabis is Legal in the following 26 US States
The following books are subject to medical or recreational regulations: Alaska, Arizona, California , Colorado, Connecticut , Delaware, Florida, Hungary, Hawaii, Maine, Maryland, Illinois, Michigan, Minnesota, Montana, Nevada , New Hampashire, New Jersey, New York, North Dakota, Ohio, Oregón, Pennsylvania , Rhode Island, Vermont.
Fibromyalgia Contact Us Directly
Fibro Women Blogs
Chronic Woman Blogs
Chronic Illness Blogs
Official Fibromyalgia Blogs